What NEXTBio Capital Management LP reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 2038158 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 3.7M |
| +18.3% |
| $25.9M |
| 11.9% |
CMPSCOMPASS Pathways plc | 1.8M | −12.2% | $25.1M | 11.6% |
GPCRStructure Therapeutics Inc. | 312.5K | +134.5% | $16.8M | 7.7% |
VORVor Biopharma Inc. | 889.2K | −11.1% | $16.4M | 7.5% |
RYTMRhythm Pharmaceuticals, Inc. | 131.8K | +4.5% | $14.6M | 6.7% |
PVLAPalvella Therapeutics, Inc. | 89.9K | +8.7% | $13.7M | 6.3% |
XENEXenon Pharmaceuticals Inc. | 183.2K | ±0% | $11.1M | 5.1% |
ZBIOZenas BioPharma, Inc. | 426.7K | ±0% | $10.8M | 5% |
ORICOric Pharmaceuticals, Inc. | 706.1K | +34.9% | $7.6M | 3.5% |
IVAInventiva S.A. | 1.8M | +34.1% | $6.8M | 3.1% |
CBIOCrescent Biopharma, Inc. | 372.9K | ±0% | $6.7M | 3.1% |
PCVXVaxcyte, Inc. | 107.2K | +12.6% | $6.2M | 2.9% |
COGTCogent Biosciences, Inc. | 131.1K | −0.1% | $5.1M | 2.3% |
VSTMVerastem, Inc. | 1.3M | ±0% | $5M | 2.3% |
IRONDisc Medicine, Inc. | 52.7K | ±0% | $3.9M | 1.8% |
PHVSPharvaris N.V. | 108.1K | New | $3.7M | 1.7% |
ZLABZai Lab Ltd | 183.4K | ±0% | $3.5M | 1.6% |
BIOABioAge Labs, Inc. | 100.7K | New | $2.5M | 1.1% |
LBRXLB Pharmaceuticals Inc | 68.2K | New | $2.2M | 1% |
EVMNEvommune, Inc. | 119.1K | −35.3% | $1.6M | 0.7% |
ACETAdicet Bio, Inc. | 157.8K | ±0% | $1.4M | 0.6% |
